Zurampic (Ironwood Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Zurampic drug offered from Ironwood Pharmaceuticals, Inc.. This Urate Transporter 1 Inhibitor [EPC],Urate Transporter 1 Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ironwood Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: lesinurad
SUBSTANCE NAME: LESINURAD
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Urate Transporter 1 Inhibitor [EPC],Urate Transporter 1 Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-09-18
END MARKETING DATE: 0000-00-00


Zurampic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZurampic from Ironwood Pharmaceuticals, Inc.
LABELER NAME: Ironwood Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2017-09-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 70785-011_ed56b54a-f47b-458f-861c-582356bab6a1
PRODUCT NDC: 70785-011
APPLICATION NUMBER: NDA207988

Other LESINURAD Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AstraZeneca Pharmaceuticals LPZURAMPIC
Ironwood Pharmaceuticals, Inc.Zurampic